Zimbabwe's main opposition leader and President
Robert Mugabe's chief rival for the last 17 years said on Tuesday he has been
diagnosed with cancer of the colon and is undergoing treatment in neighboring
South Africa.
| Opposition Movement For Democratic Change (MDC) party leader Morgan Tsvangirai speaks during a protest to mark one year since the abduction of Zimbabwean activist Itai Dzamara in Harare, March 9, 2016. |
Morgan Tsvangirai, 64, who was Zimbabwe's prime minister in an
uneasy coalition government with the 92-year-old Mugabe from 2009 until 2013,
said it was important for national leaders to disclose their health status.
Mugabe routinely denies
local media reports that he is suffering from prostate cancer and says his
frequent trips to Singapore are for routine medical checks.
"As a leader and a
public figure, I have taken a decision to make public my condition,"
Tsvangirai said, adding that he had an operation last month and is on
chemotherapy treatment.
"It is my firm
belief that the health of national leaders, including politicians, should not
be a subject of national speculation and uncertainty."
Tsvangirai, who lost the 2013 presidential vote
against Mugabe, has since 1999 led the Movement for Democratic Change (MDC) but
the party has, however, been weakened by splits over how to confront Mugabe's
ZANU-PF.
The
MDC chief, a three time loser to Mugabe, said although his condition was
unfortunate, he intended to confront "this development with the
determination to overcome it."
The
MDC, evicted from the unity government after its crushing defeat in the 2013
election, is split over whether to dump Tsvangirai before the next vote in
2018. Critics say he has often been outsmarted by Mugabe, Africa's oldest
leader.
The
turmoil within the MDC has been a boost for Mugabe, whose ZANU-PF party has
ruled Zimbabwe since independence from Britain in 1980 amid charges of rigging
recent elections.
Mugabe,
who intends to contest the 2018 vote at the age of 94, has denied rigging
previous elections.
Reuters
Sem comentários:
Enviar um comentário